Ozempic-like drugs found to be safe and effective for children with obesity, without diabe

Ozempic-like drugs found to be safe and effective for children with obesity, without diabetes. New research being presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (15–17 July), shows that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss in children of various ages without diabetes are safe and effective.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: New research being presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (15–17 July), shows that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss in children of various ages without diabetes are safe and effective. The study is by Dr.

• Ponto de atenção: ozempic.
• Ponto de atenção: like.
• Ponto de atenção: drugs.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.